KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Interest & Investment Income: 2009-2021

Historic Interest & Investment Income for Novavax (NVAX) over the last 13 years, with Dec 2021 value amounting to $1.4 million.

  • Novavax's Interest & Investment Income rose 113.38% to $303,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year increase of 34.38%. This contributed to the annual value of $1.4 million for FY2021, which is 34.52% up from last year.
  • Per Novavax's latest filing, its Interest & Investment Income stood at $1.4 million for FY2021, which was up 34.52% from $1.0 million recorded in FY2020.
  • In the past 5 years, Novavax's Interest & Investment Income ranged from a high of $2.7 million in FY2018 and a low of $1.0 million during FY2020.
  • Over the past 3 years, Novavax's median Interest & Investment Income value was $1.4 million (recorded in 2021), while the average stood at $1.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first spiked by 37.41% in 2018, then tumbled by 43.46% in 2019.
  • Yearly analysis of 5 years shows Novavax's Interest & Investment Income stood at $1.9 million in 2017, then spiked by 37.41% to $2.7 million in 2018, then tumbled by 43.46% to $1.5 million in 2019, then tumbled by 32.94% to $1.0 million in 2020, then skyrocketed by 34.52% to $1.4 million in 2021.